The accompanying unaudited interim consolidated financial statements and related notes were prepared by Escalera Resources Co. ("Escalera Resources" or the "Company"), formerly named Double Eagle Petroleum Co., in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and were prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and note disclosures normally included in the annual audited consolidated financial statements have been condensed or omitted as allowed by such rules and regulations. These consolidated financial statements include all of the adjustments, which, in the opinion of management, are necessary for a fair presentation of the financial position and results of operations. All such adjustments are of a normal recurring nature only. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full fiscal year.
The accounting policies followed by the Company are set forth in Note 1 to the Company's consolidated financial statements in its Annual Report on Form 10-K for the year ended December 31, 2013, and are supplemented in the notes to this Quarterly Report on Form 10-Q. The unaudited interim consolidated financial statements presented herein should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2013 filed with the SEC on March 13, 2014, as amended on Form 10-K/A filed with the SEC on September 12, 2014.
In August 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern ("ASU No. 2014-15") that will require management to evaluate whether there are conditions and events that raise substantial doubt about the Company's ability to continue as a going concern within one year after the financial statements are issued on both an interim and annual basis. Management will be required to provide certain footnote disclosures if it concludes that substantial doubt exists or when its plans to alleviate substantial doubt about the Company's ability to continue as a going concern. ASU No. 2014-15 becomes effective for annual periods beginning in 2016 and for interim reporting periods starting in the first quarter of 2017. The Company plans to adopt ASU No 2014-15 for its Annual Report on Form 10-K for the year ended December 31, 2016 and is in the process of evaluating the impact on its financial statement disclosures.
The unaudited interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Petrosearch Energy Corporation and Eastern Washakie Midstream LLC ("EWM"). The Company has an agreement with EWM under which the Company pays a fee to EWM to gather, compress and transport gas produced at the Catalina Unit, in the eastern Washakie Basin of Wyoming. This fee is eliminated in consolidation.
effect of outstanding vested and unvested stock options and unvested stock awards in the average number of shares of common stock outstanding during the period. Income (loss) attributable to common stock is calculated as net income (loss) less dividends paid on the Company's Series A Preferred Stock at a quarterly rate of $0.5781 per share. The Company declared and paid cash dividends of $930 for each of the three months ended September 30, 2014 and 2013 and $2,792 for each of the nine months ended September 30, 2014 and 2013.
Effective August 29, 2014, the Company replaced its existing credit facility with a new $250,000 credit agreement with Societe Generale. Under the new agreement, the Company's borrowing base was increased to $50,000. As of September 30, 2014, the Company had $45,015 outstanding on the facility. The Company paid the lender and its financial advisor structuring fees and legal expenses totaling $895 in connection with facilitating the credit agreement, which will be amortized as part of interest expense over the term of the loan.
The Company has utilized its credit facilities to fund the development of the Catalina Unit and other non-operated projects in the Atlantic Rim, development projects on the Pinedale Anticline in the Green River Basin of Wyoming, and the Company's Niobrara exploration project in the Atlantic Rim.
The credit facility is collateralized by the Company's natural gas and oil producing properties. Any balance outstanding on the credit facility is due August 28, 2017.
highest of (a) the base rate for Dollar loans for such day, Federal Funds rate for such day, plus 0.5%, or the LIBOR for such day plus (b) a margin ranging between 0.75% and 1.75% (annualized) depending on the level of funds borrowed. Under the LIBOR Rate option, interest is calculated at an annual rate equal to LIBOR, plus a margin ranging between 1.75% and 2.75% (annualized) depending on the level of funds borrowed.
The average interest rate on the new facility at September 30, 2014 was 3.1%.
For the three months ended September 30, 2014 and 2013, the Company incurred interest expense on its credit facilities of $603 and $407, respectively, and for the nine months ended September 30, 2014 and 2013, $1,427 and $1,232, respectively. Of the total interest incurred, the Company capitalized interest costs of $10 and $11 for the three months ended September 30, 2014 and 2013, respectively, and $42 and $67 for the nine months ended September 30, 2014 and 2013, respectively.
In accordance with the new credit facility, the Company is subject to both financial and non-financial covenants. The financial covenants, as defined in the credit agreement, include maintaining (i) a current ratio of 1.0 to 1.0; (ii) a ratio of earnings before interest, taxes, depreciation, depletion, amortization, exploration and other non-cash items ("EBITDAX") to interest plus dividends of greater than 1.5 to 1.0; and (iii) a funded debt, less unencumbered cash, to EBITDAX ratio of less than 4.0 to 1.0. As of September 30, 2014, the Company was in compliance with all financial and non-financial covenants under the credit facility. If the covenants are violated and the Company is unable to negotiate a waiver or amendment thereof, the lenders would have the right to declare an event of default, terminate the remaining commitment and accelerate all principal and interest outstanding.
The Company's primary market exposure is adverse fluctuations in the price of natural gas and, to a lesser extent, oil. The Company uses derivative instruments, primarily swaps and costless collars, to manage the price risk associated with its production, and the resulting impact on cash flow, net income (loss) and earnings (loss) per share. The Company does not use derivative instruments for speculative purposes.
The extent of the Company's risk management activities is controlled through policies and procedures that involve senior management and were approved by the Company's board of directors. Senior management is responsible for proposing hedging recommendations, executing the approved hedging plan, overseeing the risk management process including methodologies used for valuation and risk measurement and presenting policy changes to the Company's board of directors. The Company's board of directors is responsible for approving risk management policies and for establishing the Company's overall risk tolerance levels. The duration of the various derivative instruments depends on senior management's view of market conditions, available contract prices and the Company's operating strategy. In accordance with the Company's current credit agreement, the Company has hedged at least 85% of its projected production through 2016 based on its third-party prepared reserve report at December 31, 2013.
The Company accounts for its derivative instruments as mark-to-market derivative instruments. Under mark-to-market accounting, derivative instruments are recognized as either assets or liabilities at fair value on the Company's consolidated balance sheets, and changes in fair value are recognized in the price risk management activities line on the consolidated statements of operations. Realized gains and losses resulting from the contract settlement of derivatives are also recorded in the price risk management activities line on the consolidated statements of operations.
On the consolidated statements of cash flows, the cash flows from these instruments are classified as operating activities.
Derivative instruments expose the Company to counterparty credit risk. The Company enters into these contracts with third parties and financial institutions that it considers to be creditworthy. In addition, the Company's master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same counterparty.
As with most derivative instruments, the Company's derivative contracts contain provisions which may allow for another party to require security from the counterparty to ensure performance under the contract. The security may be in the form of, but not limited to, a letter of credit, security interest or a performance bond. As of September 30, 2014, no party to any of the Company's derivative contracts has required any form of security guarantee.
New York Mercantile Exchange ("NYMEX") Light Sweet Crude Oil ("WTI").
NYMEX Henry Hub Natural Gas ("NG").
(1)Included in price risk management activities on the consolidated statements of operations. Price risk management activities totaled $1,633 and $630 for the three months ended September 30, 2014 and 2013, respectively and $(1,634) and $1,264 for the nine months ended September 30, 2014 and 2013, respectively.
Included in interest expense, net on the consolidated statements of operations.
In conjunction with the Company entering into a new credit agreement, the Company closed out its commodity and interest rate derivative positions held with its former lender on August 29, 2014. The Company realized a gain of $1,343 on its commodity derivatives and a $315 loss on its interest rate swap. These settlements are included in the table above.
Refer to Note 5 for additional information regarding the valuation of the Company's derivative instruments.
The Company's financial instruments, including cash and cash equivalents, accounts receivable and accounts payable are carried at cost, which approximates fair value due to the short-term maturity of these instruments. The recorded value of the Company's credit facility also approximates fair value as it bears interest at a floating rate.
Level 1—Quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2—Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and model-derived valuations whose inputs or significant value drivers are observable.
Level 3—Unobservable inputs that reflect the Company's own assumptions.
The Company did not have any transfers of assets or liabilities between Level 1, Level 2 or Level 3 of the fair value measurement hierarchy during the nine months ended September 30, 2014.
The Company determines its estimates of the fair values of derivative instruments using a market approach based on several factors, including quoted prices in active markets, market-corroborated inputs, such as NYMEX forward-strip pricing, the credit rating of each counterparty, and the Company's own credit rating.
In consideration of counterparty credit risk, the Company assessed the possibility of whether each counterparty to the derivative would default by failing to make any contractually required payments. Additionally, the Company considers that it is of sufficient credit quality and has the financial resources and willingness to meet its potential repayment obligations associated with the derivative transactions.
At September 30, 2014, the Company had various types of derivative instruments, which included swaps and costless collars. The natural gas and oil derivative markets are highly active. Although the Company's economic hedges are valued using public indices, the instruments themselves are traded with third party counterparties and are not openly traded on an exchange. As such, the Company has classified these instruments as Level 2.
Refer to Note 4 for additional information regarding the Company's derivative instruments.
Financial instruments that potentially subject the Company to credit risk consist of accounts receivable and derivative financial instruments. Substantially all of the Company's receivables are within natural gas and oil industry, including those from a third party gas marketing company. Collectability is dependent upon the financial wherewithal of each counterparty as well as the general economic conditions of the industry. The receivables are not collateralized.
The Company currently uses two counterparties for its derivative financial instruments. The Company continually reviews the credit worthiness of its counterparties, which are generally other energy companies or major financial institutions. In addition, the Company uses master netting agreements which allow the Company, in the event of default, to elect early termination of all contracts with the defaulting counterparty. If the Company chooses to elect early termination, all asset and liability positions with the defaulting counterparty would be "net settled" at the time of election. "Net settlement" refers to a process by which all transactions between counterparties are resolved into a single amount owed by one party to the other.
The Company reviews the carrying values of its long-lived assets annually or whenever events or changes in circumstances indicate that such carrying values may not be recoverable. If, upon review, the sum of the undiscounted pretax cash flows is less than the carrying value of the asset group, the carrying value is written down to estimated fair value. Individual assets are grouped for impairment purposes at the lowest level for which there are identifiable cash flows that are largely independent of the cash flows of other groups of assets, generally on a field-by-field basis. The fair value of impaired assets is determined based on quoted market prices in active markets, if available, or upon the present values of expected future cash flows using discount rates commensurate with the risks involved in the asset group. The impairment analysis performed by the Company may utilize Level 3 inputs. The long-lived assets of the Company consist primarily of proved natural gas and oil properties and undeveloped leaseholds.
this area beginning in 2014. Impairment expense in the three and nine months ended September 30, 2013 was primarily related to the write-off of capital costs incurred on its Niobrara exploration well.
The Company also expensed $355 and $0 during the three months ended September 30, 2014 and 2013, respectively, and $670 and $121 during the nine months ended September 30, 2014 and 2013, respectively, related to undeveloped leaseholds. The 2014 write-off primarily related to expiring undeveloped acreage in Nebraska and Wyoming.
The Company recognized stock-based compensation expense totaling $218 and $601 for the three and nine months ended September 30, 2014, respectively, and $54 and $570, for the three and nine months ended September 30, 2013, respectively.
Compensation expense related to stock options is calculated using the Black-Scholes valuation model. Expected volatilities are based on the historical volatility of the Company's common stock over a period consistent with that of the expected terms of the options. The expected terms of the options are estimated based on factors such as vesting periods, contractual expiration dates, historical trends in the Company's common stock price and historical exercise behavior. The risk-free rates for periods within the contractual life of the options are based on the yields of U.S. Treasury instruments with terms comparable to the estimated option terms.
The Company measures the fair value of stock awards based upon the fair market value of its common stock on the date of grant and recognizes the resulting compensation expense ratably over the associated service period, which is generally the vesting term of the stock awards. The Company recognizes the compensation expenses, net of an estimated forfeiture rate, for only those shares expected to vest. The Company typically estimates forfeiture rates based on historical experience, while also considering the duration of the vesting term of the award.
In March 2014, the Company's board of directors granted long-term incentive shares to its chief executive officer ("CEO") in conjunction with his appointment as an officer. The Compensation Committee of the Board approved two restricted stock awards, under which the Company granted the CEO an aggregate of 528,634 shares of restricted stock, which are included in the table above. One-third of the shares awarded will vest at the end of three years if the CEO is continuously employed by the Company during such period, and the remaining two-thirds of the shares awarded will vest at the end of three years if the CEO is continuously employed by the Company during such period and certain performance goals related to reserve growth and the Company's common stock price are achieved, as defined for purposes of the awards. The Company used a simplified binomial model to estimate the fair value of the performance and market based component of the award. If the CEO ultimately achieves the service requirements and full performance objectives determined by the agreement, the associated total stock-based compensation expense would be approximately $881, based on the grant date fair value. The Company's stock-based compensation expense for the three and nine months ended September 30, 2014 includes approximately $58 and $122, respectively, related to these plans.
The Company is required to record income tax expense for financial reporting purposes and applies an estimated effective tax rate ("ETR") for calculating income tax provisions for interim periods. For the nine months ended September 30, 2014 the Company used an ETR of 8.4%. The Company's ETR for the nine months ended September 30, 2014 differs from the U.S. federal statutory tax rate of 35% primarily as a result of the impact of recording a valuation allowance on its net deferred tax assets.
The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of September 30, 2014, the Company made no provision for interest or penalties related to uncertain tax positions. The Company files income tax returns in the U.S. federal jurisdiction and various states. There are currently no federal or state income tax examinations of the Company underway for these jurisdictions. Furthermore, the Company is no longer subject to U.S. federal income tax examinations by the Internal Revenue Service for tax years before 2011 and for state and local tax authorities for tax years before 2010.
In 2007, the stockholders of the Company approved an amendment to the Company's Articles of Incorporation to provide for the issuance of 10,000,000 shares of preferred stock, and the Company subsequently completed a public offering of 1,610,000 shares of 9.25% Series A Cumulative Preferred Stock (the "Series A Preferred Stock") at a price of $25.00 per share.
Holders of the Series A Preferred Stock are entitled to receive, when and as declared by the Company's Board of Directors, dividends at a rate of 9.25% per annum ($2.3125 per annum per share)(the "Dividend Rate"). The Series A Preferred Stock does not have any stated maturity date and will not be subject to any sinking fund or mandatory redemption provisions except, under certain circumstances, upon a change of ownership or control. The Company may redeem the Series A Preferred Stock for cash at its option, in whole or from time to time in part, at a redemption price of $25.00 per share, plus accrued and unpaid dividends (whether or not earned or declared) to the redemption date.
The shares of Series A Preferred Stock are classified as other than of permanent equity on the consolidated balance sheets due to the change of control redemption provision applicable to such shares. Following a change of ownership or control of the Company by a person or entity in which the common stock of the Company is no longer traded on a national exchange, the Company will be required to redeem the Series A Preferred Stock within 90 days after the date on which the change of ownership or control occurred for cash. In the event of liquidation, the holders of the Series A Preferred Stock will have the right to receive $25.00 per share, plus all accrued and unpaid dividends, before any payments are made to the holders of the Company's common stock.
On March 24, 2014, the Company accepted subscription agreements for a private offering of its common stock. The gross proceeds from the private offering were $4,825, or $4,158 net of placement agent and legal fees. The offering was effected through a private placement transaction with accredited investors. The Company plans to use the net proceeds of the private offering to fund working capital needs, capital expenditures, acquisitions of interests in natural gas and oil assets, and for general corporate purposes. On April 7, 2014, the Company issued a total of 2,018,826 shares of common stock at a price of $2.39 per share to investors in such private placement transaction.
Three related parties to the Company purchased $775 of common stock through this private offering, including $350 by its chief executive officer prior to becoming an officer of the Company. The Company also reimbursed the CEO for $118 of costs he incurred related to the offering and business development as part of the private placement agreement.
In May 2014, the Company entered into a letter agreement to jointly initiate the development, construction and operations of a gas-to-liquids ("GTL") plant to be located in Wyoming (the "GTL Plant"). If a definitive agreement is reached, the Company will jointly own Escalera GTL, LLC ("EGTL") with Wyoming GTL, LLC ("WYGTL"), through which the initial phase of the GTL Plant will be executed. Under the Letter Agreement, WYGTL assigned all development and engineering plans, contracts, rights, technical relationships, among other rights (collectively, the "Rights") to EGTL, and the Company will advance up to $2,000 to EGTL. EGTL will use the funds for feasibility studies and completion of the initial engineering and development plans for the GTL Plant.
The Letter Agreement will terminate on November 26, 2014 if a definitive agreement between the Company and WYGTL has not been completed. In the event a definitive agreement is not executed within the required period, WYGTL will reimburse the Company for any portion of the $2,000 funded to EGTL, and EGTL will assign all rights back to WYGTL. Under the letter agreement, WYGTL will initially own 90% of the GTL plant, with the Company owning the remaining 10%.
For the Company's participation in EGTL, the Company anticipates being granted the right to supply up to 75% of the natural gas feedstock for the GTL Plant once it is operational, which is not expected for at least five years. Based on WYGTL's plans for the GTL Plant, the estimated amount of gas to be supplied by us would be up to approximately 35-38 Bcf annually. Additionally, the Company intends to participate in the net margin generated from the conversion of the gas it supplies to the GTL Plant in return for entering into a long-term gas supply contract.
As of September 30, 2014, the Company had advanced $871 under the agreement, which is included in other current assets on the consolidated statement of operations. To the extent that a definitive agreement is not executed with WYGTL, the Company believes that the reimbursement by WYGTL for amounts advanced under the letter agreement is fully collectible.
From time to time, the Company is involved in various legal proceedings, which are subject to the uncertainties inherent in any litigation. The Company is defending itself vigorously in all such matters, and while the ultimate outcome and impact of any proceeding cannot be predicted with certainty, management believes that the resolution of any proceeding will not have a material adverse effect on the Company's financial condition or results of operations.
The terms "Escalera Resources," "Company," "we," "our," and "us" refer to Escalera Resources Co. and its subsidiaries, as a consolidated entity, unless the context suggests otherwise. Unless the context suggests otherwise, the amounts set forth herein are in thousands, except units of production, dollar per unit of production, ratios, and share or per share amounts.
The outcome of any future litigation or similar disputes and the impact on any such outcome or related settlements.
We may also make material acquisitions or divestitures or enter into financing or other transactions. None of these events can be predicted with certainty, and the possibility of such events occurring is not taken into consideration in the forward-looking statements.
New factors that could cause actual results to differ materially from those described in forward-looking statements emerge from time to time, and it is not possible for us to predict all such factors, or the extent to which any such factor or combination of factors may cause actual results to differ from those contained in any forward-looking statement. We assume no obligation to publicly update or revise any such forward-looking statements, whether as a result of new information, future events, or otherwise.
We are an independent energy company currently engaged in the exploration, development, production and sale of natural gas and crude oil, primarily in the Rocky Mountain Basins of the western United States. We were incorporated in Wyoming in 1972 and reincorporated in Maryland in 2001. Our board of directors appointed a new chief executive officer, Charles F. Chambers, effective April 1, 2014, and in conjunction with this change, we changed our name to Escalera Resources Co. from Double Eagle Petroleum Co. Our common stock and Series A Cumulative Preferred are both publicly traded on the NASDAQ Global Select Market under the symbols "ESCR" and "ESCRP", respectively. Our corporate offices are located at 1675 Broadway, Suite 2200, Denver, Colorado 80202, telephone number (303) 794-8445. Our executive offices are located at 675 Bering, Suite 850, Houston, TX 77057. Our website is www.escaleraresources.com.
Our objective is to increase long-term shareholder value by profitably growing our reserves, production, revenues, and cash flow. To meet this objective, we primarily focus on: (i) selectively pursuing strategic acquisitions of abundant, low cost natural gas assets that are currently undervalued or underutilized; (ii) identifying alternative ways to enhance the value of our natural gas reserves; (iii) investment in and enhancement of existing production wells and field facilities on operated and non-operated properties in the Atlantic Rim; (iv) continued participation in the development of tight sands gas wells at the Mesa Units on the Pinedale Anticline; and (v) pursuit of high quality exploration and strategic development projects with potential for providing long-term drilling inventories that we believe will generate above average returns.
Our current production primarily consists of natural gas from our two core properties in Wyoming. We have coalbed methane ("CBM") reserves and production in the Atlantic Rim area of the eastern Washakie Basin and tight gas reserves and production on the Pinedale Anticline in the Green River Basin.
Our Atlantic Rim and Pinedale Anticline assets operate under federal exploratory unit agreements among the working interest partners. Unitization is a type of sharing arrangement by which owners of operating and non-operating working interests pool their property interests in a producing area to form a single operating unit. Units are designed to improve efficiency and economics of developing and producing an area. The share that each interest owner receives is based upon the respective acreage contributed by each owner in the participating area ("PA") that surround the producing wells as a percentage of the entire acreage of the PA.
In May 2014, we entered into a letter agreement to jointly initiate the development, construction and operations of a gas-to-liquids ("GTL") plant to be located in Wyoming (the "GTL Plant"). If a definitive agreement is reached, we will jointly own Escalera GTL, LLC ("EGTL") with Wyoming GTL, LLC ("WYGTL"), through which the initial phase of the GTL Plant will be executed. Under the letter agreement, WYGTL assigned all development and engineering plans, contracts, rights, technical relationships, among other rights (collectively, the "Rights") to EGTL, and we will advance up to $2,000 to EGTL. EGTL will use the funds for feasibility studies and completion of the initial engineering and development plans for the GTL Plant.
Currently the letter agreement will terminate on November 26, 2014 if a definitive agreement between us and WYGTL has not been completed. We are in the process of negotiating an extension on the letter agreement to January 31, 2015. In the event a definitive agreement is not executed within the required period, WYGTL will reimburse us for any portion of the $2,000 funded to EGTL, and EGTL will assign all rights back to WYGTL. Under the letter agreement, WYGTL will initially own 90% of the GTL plan and we will own the remaining 10%.
For our participation in EGTL, we anticipate being granted the right to supply up to 75% of the natural gas feedstock for the GTL Plant once it is operational, which is not expected for at least for five years. Based on WYGTL's plans for the GTL Plant, the estimated amount of gas to be supplied by us would be up to approximately 35-38 Bcf annually. Additionally, we intend to participate in the net margin generated from the conversion of the gas we supply to the GTL Plant in return for entering into a long-term gas supply contract.
Management believes this arrangement provides significant opportunity for the Company to enhance the pricing ultimately realized from its natural gas production. As of September 30, 2014, $871 of the $2,000 commitment had been advanced. To the extent that a definitive agreement is not executed with WYGTL, we believe that the reimbursement by WYGTL for amounts advanced under the letter agreement is fully collectible.
On August 29, 2014, we replaced our existing credit facility with a $250 million credit facility with Societe Generale. The new credit facility increased our borrowing base to $50 million and extended the maturity date to August 2017. The new facility also has a more flexible covenant structure than our previous credit facility, which management believes to be essential as we expand our business.
The following analysis provides comparison of the three months ended September 30, 2014 and the three months ended September 30, 2013.
Natural gas and oil sales decreased 1% to $7,550, due to an 11% decrease in natural gas production, primarily at our Atlantic Rim and Pinedale Anticline properties. The decrease in production volumes was partially offset by a 12% increase in the Colorado Interstate Gas ("CIG") market price, which is the index on which most of our natural gas volumes are sold.
As shown in the table below, our average realized natural gas price decreased 6% to $3.61 per Mcf. We calculate our average realized natural gas price by summing (1) production revenues received from third parties for the sale of our gas, which is included within natural gas and oil sales on the consolidated statements of operations, and (2) realized gain on our commodity derivatives, which is included within price risk management activities, net on the consolidated statements of operations, totaling $115 and $1,658 for the three months ended September 30, 2014 and 2013, respectively. The 2014 net realized gain on commodity contracts considered in the average realized price calculation, excluded the $1,343 gain realized on the settlement of our commodity contracts with the prior lender on our credit facility.
Our total net production decreased 11% to 2.0 Bcfe for the three months ended September 30, 2014 primarily due to lower production from our non-operated properties at the Spyglass Hill Unit and on the Pinedale Anticline.
Our total average daily net production at the Atlantic Rim decreased 10% to 16,414 Mcfe. Our Atlantic Rim production comes from two operating units: the Catalina Unit and the Spyglass Hill Unit (which includes the Sun Dog, Doty Mountain, and Grace Point PAs). We operate the Catalina Unit and have non-operated working interests in the Spyglass Hill Unit.


text:
IL "GRANDE RESET ALIMENTARE": CHI C'È DIETRO IL PIANO PER RIORGANIZZARE L'APPROVVIGIONAMENTO ALIMENTARE GLOBALE?
I GRANDI DISTRUTTORI DELL'AMBIENTE E DELL'UMANITÀ SE LA CAVANO SENZA PROBLEMI – LA GUERRA CONTINUA AD ESSERE PROPAGANDATA
GLI SCIENZIATI SI APPELLANO PER LA PROTEZIONE DALL'ESPOSIZIONE A RADIAZIONI NON IONIZZANTI
Maria Heibel — 28 Giugno 2018
L' 11 Maggio 2015 è stato presentato un appello internazionale per la protezione dall'esposizione a campi elettromagnetici, sottoscritto da 190 scienziati di 39 nazioni alle Nazioni Unite, agli stati membri delle Nazioni Unite e all'Organizzazione Mondiale della Sanità. Questi scienziati hanno complessivamente pubblicato oltre 2000 articoli scientifici peer-reviewed sugli effetti biologici e sanitari delle radiazioni non ionizzanti, quello parte dello spettro elettromagnetico che include i campi a bassissima frequenza (ELF) utilizzati per l'elettricità e la radio frequenza, usata per le comunicazioni senza filo.
Il Dr. Martin Blank, in un video di tre minuti, introduce il contenuto e l'importanza dell'appello. Il Dr. Blank ha sulle spalle 30 anni di esperienza nella conduzione di ricerca riguardante i campi elettromagnetici presso la Columbia University ed è stato presidente dell'International Bioelectromagnetics Society. Nelle sue schiette parole, emerge l'impellente necessità di affrontare la questione di salute pubblica posta dall'inquinamento ambientale generalizzato derivante dalla proliferazione incontrollata di sorgenti di campi elettromagnetici che ci riguarda tutti.
Il contenuto del video del Dr. Martin Blank è reso disponibile, tradotto in italiano, di seguito:
Sono qui con inquietanti notizie sui nostri gadget preferiti: telefoni cellulari, tablets, Wi-Fi, etc.
Per dirla senza mezzi termini, essi stanno danneggiando le cellule viventi nel nostro corpo e uccidendo molti di noi prematuramente.
Sono il Dr. Martin Blank, del Dipartimento di Fisiologia e Biofisica Cellulare alla Columbia University.
E' doloroso per me, e per più di 160 colleghi, che oggi hanno sottoscritto una petizione alle Nazioni Unite, chiedendo loro che affrontino questo problema.
Siamo scienziati e ingegneri, e sono qui per dirvi – abbiamo creato qualcosa che ci sta facendo male, e che sta andando fuori controllo!
Prima della lampadina di Edison, c'era pochissima radiazione elettromagnetica nel nostro ambiente. I livelli di oggi sono molte molte volte più alti dei livelli del fondo naturale e stanno crescendo rapidamente a causa di tutti i nuovi dispositivi che emettono questa radiazione.
Un esempio che molti di noi hanno in tasca in questo momento è il telefono cellulare. Uno studio mostra che da quando l'utilizzo del telefono cellulare si è ampiamente diffuso, l'incidenza di tumore cerebrale fatale nelle persone più giovani si è più che triplicato.
Stiamo installando antenne cellulari in edifici residenziali, e in cima agli ospedali, dove le persone stanno cercando di guarire.
I contatori intelligenti wireless e le stazioni radio base telefoniche stanno diffondendo radiazioni nei nostri quartieri.
E' particolarmente inquietante il fatto che le radiazioni della nostra tecnologia di telecomunicazioni e di distribuzione energetica danneggi il DNA nelle nostre cellule. E' chiaro a molti biologi che questo può spiegare i tassi in aumento di cancro.
Le generazioni future – I NOSTRI BAMBINI – SONO A RISCHIO.
Questi biologi e scienziati non vengono ascoltati dai comitati che stabiliscono gli standard di sicurezza.
I fatti BIOLOGICI vengono ignorati, e come risultato i limiti di sicurezza sono troppo alti.
ESSI NON SONO PROTETTIVI!
Verrà fuori più protezione probabilmente dalla piena divulgazione di possibili conflitti di interesse tra le autorità di regolamentazione e l'industria.
L'aumento dell'esposizione alle radiazioni elettromagnetiche è un problema GLOBALE. L'Organizzazione Mondiale della Sanità e gli enti per la definizione degli standard internazionali non stanno agendo per proteggere la salute pubblica e il benessere.
Le linee guida internazionali per l'esposizione devono essere rafforzate per riflettere la realtà del loro impatto sui nostri corpi, e in particolare, sul nostro DNA.
Anche se siamo ancora nel bel mezzo di una grande trasformazione tecnologica, si è in forte ritardo nell'affrontare gli effetti negativi biologici e sulla salute.
Siamo davvero tutti parte di un grande esperimento biologico, senza il nostro consenso informato.
Per proteggere i nostri figli, noi stessi, e il nostro ecosistema, dobbiamo ridurre l'esposizione attraverso la definizione di linee guida più protettive.
E così, oggi, gli scienziati di tutto il mondo stanno presentando un appello alle Nazioni Unite, i suoi stati membri e all'Organizzazione Mondiale della Sanità, per fornire una leadership nell'affrontare questa crisi della salute pubblica.
Il testo dell'appello internazionale, tradotto in italiano è accessibile qui.
L'appello formula delle richieste molto precise e pressanti.
"Collettivamente chiediamo che:
1. Vengano protetti i bambini e le donne incinta;
2. Si rinforzino le linee guida e gli standard regolamentari;
3. I produttori vengano incoraggiati a sviluppare tecnologia più sicura;
4. I servizi di utilità pubblica (società dell'energia elettrica, telefonia, etc.) responsabili della produzione, trasmissione, distribuzione, e monitoraggio del mantenimento dell'elettricità, mantengano di un'adeguata qualità della corrente elettrica e assicurino cavi elettrici appropriati per minimizzare i danni prodotti dalla corrente a terra;
5. Il pubblico venga pienamente informato riguardo ai rischi potenziali per la salute derivanti dall'energia elettromagnetica e vengano loro insegnate le strategie per la riduzione del danno;
6. Ai professionisti del campo medico si provveda un'educazione adeguata riguardo agli effetti biologici dell'energia elettromagnetica e sia provvista una formazione al trattamento di pazienti che soffrono di elettrosensibilità;
7. I governi finanzino formazione e ricerca sui campi elettromagnetici e la salute che sia indipendente dall'industria e impongano la cooperazione tra industria e ricercatori;
8. I mass media rivelino i rapporti tra gli esperti della finanza con l'industria quando citano le loro opinioni riguardo gli aspetti sulla salute e la sicurezza delle tecnologie di emissione di EMF; e
9. Vengano stabilite delle zone-bianche (aree libere da radiazioni)."
Riferimenti:
[1] EMFScientist.org website
[2] Traduzione italiana appello internazionale
[3] Video introduzione appello Dr. Martin Blank
http://www.elettrosmogsicilia.org/notizie/98-2015/286-gli-scienziati-si-appellano
Hanno firmato attualmente 240 Scienziati
As of June 15, 2018, 240 EMF scientists from 41 nations have signed the Appeal
Prof. Sinerik Ayrapetyan, Ph.D., UNESCO Chair – Life Sciences International Postgraduate Educational Center, Armenia
Dr. Priyanka Bandara, Ph.D., Independent Env.Health Educator/Researcher, Advisor, Environmental Health Trust; Doctors for Safer Schools, Australia
Dr. Peter French BSc, MSc, MBA, PhD, FRSM, Conjoint Senior Lecturer, University of New South Wales, Australia
Dr. Bruce Hocking, MD, MBBS, FAFOEM (RACP), FRACGP, FARPS, specialist in occupational medicine; Victoria, Australia
Dr. Gautam (Vini) Khurana, Ph.D., F.R.A.C.S., Director, C.N.S. Neurosurgery, Australia
Dr. Don Maisch, Ph.D., Australia
Dr. Elena Pirogova, Ph.D., Biomed Eng., B. Eng (Hon) Chem. Eng., Engineering & Health College; RMIT University, Australia
Dr. Mary Redmayne, Ph.D., Department of Epidemiology & Preventive Medicine, Monash University, Australia
Dr. Charles Teo, BM, BS, MBBS, Member of the Order of Australia, Director, Centre for Minimally Invasive Neurosurgery at Prince of Wales Hospital, NSW, Australia
Dr. Michael Kundi, MD, University of Vienna, Austria
Dr. Gerd Oberfeld, MD, Public Health Department, Salzburg Government, Austria
Dr. Bernhard Pollner, MD, Pollner Research, Austria
Prof. Dr. Hugo W. Rüdiger, MD, Austria
Dr. Amer Kamal, MD, Physiology Department, College of Medicine, Arabian Gulf University, Bahrain
Prof. Marie-Claire Cammaerts, Ph.D., Free University of Brussels, Faculty of Science, Brussels, Belgium
Dr. Andre Vander Vorst, PhD, Professor Emeritus, University Louvain-la-Neuve, Belgium
Vânia Araújo Condessa, MSc., Electrical Engineer, Belo Horizonte, Brazil
Prof. Dr. João Eduardo de Araujo, MD, University of Sao Paulo, Brazil
Dr. Francisco de Assis Ferreira Tejo, D. Sc., Universidade Federal de Campina Grande, Campina Grande, State of Paraíba, Brazil
Prof. Alvaro deSalles, Ph.D., Federal University of Rio Grande Del Sol, Brazil
Prof. Adilza Dode, Ph.D., MSc. Engineering Sciences, Minas Methodist University, Brazil
Dr. Daiana Condessa Dode, MD, Federal University of Medicine, Brazil
Michael Condessa Dode, Systems Analyst, MRE Engenharia Ltda, Belo Horizonte, Brazil
Prof. Orlando Furtado Vieira Filho, PhD, Cellular&Molecular Biology, Federal University of Rio Grande do Sul, Brazil
Dr. Magda Havas, Ph.D., Environmental and Resource Studies, Centre for Health Studies, Trent University, Canada
Dr. Paul Héroux, Ph.D., Director, Occupational Health Program, McGill University; InvitroPlus Labs, Royal Victoria Hospital, McGill University, Canada
Dr. Tom Hutchinson, Ph.D., Professor Emeritus, Environmental and Resource Studies, Trent University, Canada
Prof. Ying Li, Ph.D., InVitroPlus Labs, Dept. of Surgery, Royal Victoria Hospital, McGill University, Canada
James McKay M.Sc, Ecologist, City of London; Planning Services, Environmental and Parks Planning, London, Canada
Prof. Anthony B. Miller, MD, FRCP, University of Toronto, Canada
Prof. Klaus-Peter Ossenkopp, Ph.D., Department of Psychology (Neuroscience), University of Western Ontario, Canada
Dr. Malcolm Paterson, PhD. Molecular Oncologist (ret.), British Columbia, Canada
Prof. Michael A. Persinger, Ph.D., Behavioural Neuroscience and Biomolecular Sciences, Laurentian University, Canada
Prof. Huai Chiang, Bioelectromagnetics Key Laboratory, Zhejiang University School of Medicine, China
Prof. Yuqing Duan, Ph.D., Food & Bioengineering, Jiangsu University, China
Dr. Kaijun Liu, Ph.D., Third Military Medical University, Chongqing, China
Prof. Xiaodong Liu, Director, Key Lab of Radiation Biology, Ministry of Health of China; Associate Dean, School of Public Health, Jilin University, China
Prof. Wenjun Sun, Ph.D., Bioelectromagnetics Key Lab, Zhejiang University School of Medicine, China
Prof. Minglian Wang, Ph.D., College of Life Science & Bioengineering, Beijing University of Technology, China
Prof. Qun Wang, Ph.D., College of Materials Science & Engineering, Beijing University of Technology, China
Prof. Haihiu Zhang, Ph.D., School of Food & BioEngineering, Jiangsu University, China
Prof. Jianbao Zhang, Associate Dean, Life Science and Technology School, Xi'an Jiaotong University, China
Prof. Hui-yan Zhao, Director of STSCRW, College of Plant Protection, Northwest A & F University, Yangling Shaanxi, China
Prof. J. Zhao, Department of Chest Surgery, Cancer Center of Guangzhou Medical University, Guangzhou, China
Ivancica Trosic, Ph.D., Institute for Medical Research and Occupational Health, Croatia
Prof. Dr. Abu Bakr Abdel Fatth El-Bediwi, Ph.D., Physics Dept., Faculty of Science, Mansoura University, Egypt
Prof. Dr. Emad Fawzy Eskander, Ph.D., Medical Division, Hormones Department, National Research Center, Egypt
Prof. Dr. Heba Salah El Din Aboul Ezz, Ph.D., Physiology, Zoology Department, Faculty of Science, Cairo University, Egypt
Prof. Dr. Nasr Radwan, Ph.D., Neurophysiology, Faculty of Science, Cairo University, Egypt
Dr. Hiie Hinrikus, Ph.D., D.Sc, Tallinn University of Technology, Estonia
Mr. Tarmo Koppel, Tallinn University of Technology, Estonia
Dr. Mikko Ahonen, Ph.D, University of Tampere, Finland
Dr. Marjukka Hagström, LL.M., M.Soc.Sc, Principal Researcher, Radio and EMC Laboratory, Finland
Prof. Dr. Osmo Hänninen, Ph.D., Dept. of Physiology, Faculty of Medicine, University of Eastern Finland, Finland; Editor-In-Chief, Pathophysiology, Finland
Dr. Dariusz Leszczynski, Ph.D., Adjunct Professor of Biochemistry, University of Helsinki, Finland; Member of the IARC Working Group that classified cell phone radiation as possible carcinogen.
Dr. Georgiy Ostroumov, Ph.D. (in the field of RF EMF), independent researcher, Finland
Prof. Dr. Dominique Belpomme, MD, MPH, Professor in Oncology, Paris V Descartes University, ECERI Executive Director
Dr. Pierre Le Ruz, Ph.D., Criirem, Le Mans, France Georgia
Dr Annie J Sasco, MD, MPH, MS, DrPH, Former Research Director at the French NIH (INSERM), Former Chief, Unit of Epidemiology for Cancer Prevention at the International Agency for Research on Cancer, Former Acting Head, Programme for Cancer Control, World Health Organization, Bordeaux, France.
Prof. Besarion Partsvania, Ph.D., Head of Bio-cybernetics Department of Georgian Technical University, Georgia
Prof. Dr. Franz Adlkofer, MD, Chairman, Pandora Foundation, Germany
Prof. Dr. Hynek Burda, Ph.D., University of Duisburg-Essen, Germany
Dr. Horst Eger, MD, Electromagnetic Fields in Medicine, Association of Statutory Health Insurance Physicians, Bavaria, Germany
Prof. Dr. Karl Hecht, MD, former Director, Institute of Pathophysiology, Charité, Humboldt University, Berlin, Germany
Dr.Sc. Florian M. König, Ph.D., Florian König Enterprises (FKE) GmbH, Munich, Germany
Dr. rer. nat. Lebrecht von Klitzing, Ph.D., Dr. rer. nat. Lebrecht von Klitzing, Ph.D., Head, Institute of Environ.Physics; Ex-Head, Dept. Clinical Research, Medical University, Lubeck, Germany
Dr. Cornelia Waldmann-Selsam, MD, Member, Competence Initiative for the Protection of Humanity, Environment and Democracy e.V, Bamberg, Germany
Dr. Ulrich Warnke, Ph.D., Bionik-Institut, University of Saarlandes, Germany
Dr. Adamantia F. Fragopoulou, M.Sc., Ph.D., Department of Cell Biology & Biophysics, Biology Faculty, University of Athens, Greece
Dr. Christos Georgiou, Ph.D., Biology Department, University of Patras, Greece
Prof. Emeritus Lukas H. Margaritis, Ph.D., Depts. Cell Biology, Radiobiology & Biophysics, Biology Faculty, Univ. of Athens, Greece
Dr. Aikaterini Skouroliakou, M.Sc., Ph.D., Department of Energy Technology Engineering, Technological Educational Institute of Athens, Greece
Dr. Stelios A Zinelis, MD, Hellenic Cancer Society-Kefalonia, Greece
Dr. Ceon Ramon, Ph.D., Affiliate Professor, University of Washington, USA; Professor, Reykjavik University, Iceland
Prof. Dr. B. D. Banerjee, Ph.D., Fmr. Head, Environmental Biochemistry & Molecular Biology Laboratory, Department of Biochemistry, University College of Medical Sciences, University of Delhi, India
Prof. Jitendra Behari, Ph.D., Ex-Dean, Jawaharlal Nehru University; presently, Emeritus Professor, Amity University, India
Prof. Dr. Madhukar Shivajirao Dama, Institute of Wildlife Veterinary Research, India
Associate Prof. Dr Amarjot Dhami, PhD., Lovely Professional University, Phagwara, Punjab, India
Dr. Kavindra K. Kesari, MBA, Ph.D., Resident Environmental Scientist, University of Eastern Finland, Finland; Assistant Professor, Jaipur National University, India
Prof. Girish Kumar, Ph.D., Electrical Engineering Department, Indian Institute of Technology, Bombay, India
Dr. Pabrita Mandal PhD.,Department of Physics, Indian Institute of Technology, Kanpur, India
Prof. Rashmi Mathur, Ph.D., Head, Department of Physiology, All India Institute of Medical Sciences, New Delhi, India
Prof. Dr. Kameshwar Prasad MD, Head, Dept of Neurology, Director, Clinical Epidemiology, All India Institute of Medical Sciences, India
Dr. Sivani Saravanamuttu, PhD., Dept. Advanced Zoology and Biotechnology, Loyola College, Chennai, India
Dr. N.N. Shareesh, PhD., Melaka Manipal Medical College, India
Dr. R.S. Sharma, MD, Sr. Deputy Director General, Scientist – G & Chief Coordinator – EMF Project, Indian Council of Medical Research, Dept. of Health Research, Ministry/Health and Family Welfare, Government of India, New Delhi, India
Prof. Dr. Dorairaj Sudarsanam, M.Sc., M.Ed., Ph.D., Fellow – National Academy of Biological Sciences, Prof. of Zoology, Biotechnology and Bioinformatics, Dept. Advanced Zoology & Biotechnology, Loyola College, Chennai, South India
Prof. Dr. Soheila Abdi, Ph.D., Physics, Islamic Azad University of Safadasht, Tehran, Iran
Prof. G.A. Jelodar, D.V.M., Ph.D., Physiology, School of Veterinary Medicine, Shiraz University, Iran
Prof. Hamid Mobasheri, Ph.D., Head BRC; Head, Membrane Biophysics&Macromolecules Lab; Instit. Biochemistry&Biophysics, University, Tehran, Iran
Prof. Seyed Mohammad Mahdavi, PhD., Dept of Biology, Science and Research, Islamic Azad University, Tehran, Iran
Prof. S.M.J. Mortazavi, Ph.D., Head, Medical Physics & Engineering; Chair, NIER Protection Research Center, Shiraz University of Medical Sciences, Iran
Prof. Amirnader Emami Razavi, Ph.D., Clinical Biochem., National Tumor Bank, Cancer Institute, Tehran Univ. Medical Sciences, Iran
Dr. Masood Sepehrimanesh, Ph.D., Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Iran
Prof. Dr. Mohammad Shabani, Ph.D., Neurophysiology, Kerman Neuroscience Research Center, Iran
Michael Peleg, M.Sc., radio communications engineer and researcher, Technion – Israel Institute of Technology, Israel
Prof. Elihu D. Richter, MD,MPH, Occupational&Environmental Medicine, Hebrew University-Hadassah School of Public Health&Community Medicine, Israel
Dr. Yael Stein, MD, Hebrew University of Jerusalem, Hadassah Medical Center, Israel
Dr. Danny Wolf, MD, Pediatrician and General Practitioner, Sherutey Briut Clalit, Shron Shomron district, Israel
Dr. Ronni Wolf, MD, Assoc. Clinical Professor, Head of Dermatology Unit, Kaplan Medical Center, Rehovot, Israel
Prof. Sergio Adamo, Ph.D., La Sapienza University, Rome, Italy
Prof. Fernanda Amicarelli, Ph.D., Applied Biology, Dept. of Health, Life and Environmental Sciences, University of L'Aquila, Italy
Dr. Pasquale Avino, Ph.D., INAIL Research Section, Rome, Italy
Dr. Fiorella Belpoggi, Ph.D., FIATP, Director, Cesare Maltoni Cancer Research Center, Ramazzini Institute, Italy
Prof. Giovanni Di Bonaventura, PhD, School of Medicine, "G. d'Annunzio" University of Chieti-Pescara, Italia
Prof. Emanuele Calabro, Department of Physics and Earth Sciences, University of Messina, Italy
Prof. Franco Cervellati, Ph.D., Department of Life Science and Biotechnology, Section of General Physiology, University of Ferrara, Italy
Vale Crocetta, Ph.D. Candidate, Biomolecular and Pharmaceutical Sciences, "G. d'Annunzio" University of Chieti, ItalyProf. Stefano Falone, Ph.D., Researcher in Applied Biology, Dept. of Health, Life&Environmental Sciences, University of L'Aquila, Italy
Prof. Dr. Speridione Garbisa, ret. Senior Scholar, Dept. Biomedical Sciences, University of Padova, Italy
Dr. Settimio Grimaldi, Ph.D., Associate Scientist, National Research Council, Italy
Prof. Livio Giuliani, Ph.D., Director of Research, Italian Health National Service, Rome-Florence-Bozen; Spokesman, ICEMS-International Commission for Electromagnetic Safety, Italy
Prof. Dr. Angelo Levis, MD, Dept. Medical Sciences, Padua University, Italy
Prof. Salvatore Magazù, Ph.D., Department of Physics and Science, Messina University, Italy
Dr. Fiorenzo Marinelli, Ph.D., Researcher, Molecular Genetics Institute of the National Research Council, Italy
Dr. Arianna Pompilio, PhD, Dept. Medical, Oral & Biotechnological Sciences. G. d'Annunzio University of Chieti-Pescara, Italy
Prof. Dr. Raoul Saggini, MD, School of Medicine, University G. D'Annunzio, Chieti, Italy
Dr. Morando Soffritti, MD, Honorary President, National Institute for the Study and Control of Cancer and Environmental Diseases, B.Ramazzini, Bologna. ItalyProf. Massimo Sperini, Ph.D., Center for Inter-University Research on Sustainable Development, Rome, Italy
Prof. Tsuyoshi Hondou, Ph.D., Graduate School of Science, Tohoku University, Japan
Prof. Hidetake Miyata, Ph.D., Department of Physics, Tohoku University, Japan
Prof. Mohammed S.H. Al Salameh, Jordan University of Science & Technology , Jordan
Prof. Dr, Timur Saliev, MD, Ph.D., Life Sciences, Nazarbayev University, Kazakhstan; Institute Medical Science/Technology, University of Dundee, UK
Dr. Bruce Rapley, BSc, MPhil, Ph.D., Principal Consulting Scientist, Atkinson & Rapley Consulting Ltd., New Zealand
Dr. Idowu Ayisat Obe, Department of Zoology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria
Prof. Olatunde Michael Oni, Ph.D, Radiation & Health Physics, Ladoke Akintola University of Technology, Ogbomoso, Nigeria
Prof. Najam Siddiqi, MBBS, Ph.D., Human Structure, Oman Medical College, Oman
Dr. Pawel Bodera, Pharm. D., Department of Microwave Safety, Military Institute of Hygiene and Epidemiology, Poland
Prof. Dr. Stanislaw Szmigielski, MD, Ph.D., Military Institute of Hygiene and Epidemiology, Poland
Alina Cobzaru, Engineer, National Institutes Research & Development and Institute of Construction & Sustainability, Romania
Prof. Vladimir N. Binhi, Ph.D., A.M.Prokhorov General Physics Institute of the Russian Academy of Sciences; M.V.Lomonosov Moscow State University
Dr. Oleg Grigoyev, DSc., Ph.D., Deputy Chairman, Russian National Committee on Non-Ionizing Radiation Protection, Russian Federation
Prof. Yury Grigoryev, MD, Chairman, Russian National Committee on Non-Ionizing Radiation Protection, Russian Federation
Dr. Anton Merkulov, Ph.D., Russian National Committee on Non-Ionizing Radiation Protection, Moscow, Russian Federation
Dr. Maxim Trushin, PhD., Kazan Federal University, Russia
Dr. Snezana Raus Balind, Ph.D., Research Associate, Institute for Biological Research "Sinisa Stankovic", Belgrade, Serbia
Prof. Danica Dimitrijevic, Ph.D., Vinca Institute of Nuclear Sciences, University of Belgrade, Serbia
Dr. Sladjana Spasic, Ph.D., Institute for Multidisciplinary Research, University of Belgrade, Serbia
Dr. Igor Belyaev, Ph.D., Dr.Sc., Cancer Research Institute, Slovak Academy of Science, Bratislava, Slovak Republic
Prof. Young Hwan Ahn, MD, Ph.D, Ajou University Medical School, South Korea
Prof. Kwon-Seok Chae, Ph.D., Molecular-ElectroMagnetic Biology Lab, Kyungpook National University, South Korea
Prof. Dr. Yoon-Myoung Gimm, Ph.D., School of Electronics and Electrical Engineering, Dankook University, South Korea
Prof. Dr. Myung Chan Gye, Ph.D., Hanyang University, South Korea
Prof. Dr. Mina Ha, MD, Dankook University, South Korea
Prof. Seung-Cheol Hong, MD, Inje University, South Korea
Prof. Dong Hyun Kim, Ph.D., Dept. of Otorhinolaryngology-Head and Neck Surgery, Incheon St. Mary's Hospital, Catholic University of Korea, South Korea
Prof. Hak-Rim Kim, Dept.of Pharmacology, College of Medicine, Dankook University, South Korea
Prof. Myeung Ju Kim, MD, Ph.D., Department of Anatomy, Dankook University College of Medicine, South Korea
Prof. Jae Seon Lee, MD, Department of Molecular Medicine, NHA University College of Medicine, Incheon 22212, South Korea
Prof. Yun-Sil Lee, Ph.D., Ewha Woman's University, South Korea
Prof. Dr. Yoon-Won Kim, MD, Ph.D., Hallym University School of Medicine, South Korea
Prof. Jung Keog Park, Ph.D., Life Science & Biotech; Dir., Research Instit.of Biotechnology, Dongguk University, South Korea
Prof. Sungman Park, Ph.D., Institute of Medical Sciences, School of Medicine, Hallym University, South Korea
Prof. Kiwon Song, Ph.D., Dept. of Chemistry, Yonsei University, South Korea
Prof. Dr. Miguel Alcaraz, MD, Ph.D., Radiology and Physical Medicine, Faculty of Medicine, University of Murcia, Spain
Dr. Alfonso Balmori, Ph.D., Biologist, Consejería de Medio Ambiente, Junta de Castilla y León, Spain
Prof. J.L. Bardasano, D.Sc, University of Alcalá, Department of Medical Specialties, Madrid, Spain
Dr. Claudio Gómez-Perretta, MD, Ph.D., La Fe University Hospital, Valencia, Spain
Prof. Dr. Miguel López-Lázaro, PhD., Associate Professor, Department of Pharmacology, University of Seville, Spain
Prof. Dr. Elena Lopez Martin, Ph.D., Human Anatomy, Facultad de Medicina, Universidad de Santiago de Compostela, Spain
Dr. Emilio Mayayo, MD, Professor of Pathology, School of Medicine, University Rovira I Virgili (URV), Tarragona, Spain
Prof. Enrique A. Navarro, Ph.D., Department of Applied Physics and Electromagnetics, University of Valencia, Spain
Dr. Michael Carlberg, MSc, Örebro University Hospital, Sweden
Dr. Lennart Hardell, MD, Ph.D., University Hospital, Örebro, Sweden
Dr. Lena Hedendahl, MD, Independent Environment and Health Research Luleå, Sweden
Prof. Olle Johansson, Ph.D., Experimental Dermatology Unit, Dept. of Neuroscience, Karolinska Institute, Sweden
Dr. Bertil R. Persson, Ph.D., MD, Lund University, Sweden
Senior Prof. Dr. Leif Salford, MD. Department of Neurosurgery, Director, Rausing Laboratory, Lund University, Sweden
Dr. Fredrik Söderqvist, Ph.D., Ctr. for Clinical Research, Uppsala University, Västerås, Sweden
Dr. phil. nat. Daniel Favre, A.R.A. (Association Romande Alerte, Switzerland
Taiwan (Republic of China)
Prof. Dr. Tsun-Jen Cheng, MD, Sc.D., National Taiwan University, Republic of China
Prof. Dr. Mehmet Zülküf Akdağ, Ph.D., Department of Biophysics, Medical School of Dicle University, Diyarbakir, Turkey
Associate Prof.Dr. Halil Abraham Atasoy, MD, Pediatrics, Abant Izzet Baysal University, Faculty of Medicine, Turkey
Prof. Ayse G. Canseven (Kursun), Ph.D., Gazi University, Faculty of Medicine, Dept. of Biophysics, Turkey
Prof. Dr. Mustafa Salih Celik, Ph.D., Fmr. Head, Turkish Biophysical Society; Head, Biophysics Dept; Medical Faculty, Dicle Univ., Turkey
Prof. Dr. Osman Cerezci, Electrical-Electronics Engineering Department, Sakarya University, Turkey
Prof. Dr. Suleyman Dasdag, Ph.D., Dept. of Biophysics, Medical School of Dicle University, Turkey
Prof. Omar Elmas, MD, Ph.D., Mugla Sitki Kocman University, Faculty of Medicine, Department of Physiology, Turkey
Prof. Dr. Ali H. Eriş, MD, faculty, Radiation Oncology Department, BAV University Medical School, Turkey
Prof. Dr. Arzu Firlarer, M.Sc. Ph.D., Occupational Health & Safety Department, Baskent University, Turkey
Prof. Associate Prof. Ayse Inhan Garip, PdH., Marmara Univ. School of Medicine, Biophysics Department, Turkey
Prof. Suleyman Kaplan, Ph.D., Head, Department of Histology and Embryology, Medical School, Ondokuz Mayıs University, Samsun, Turkey.
Prof. Dr. Mustafa Nazıroğlu, Ph.D., Biophysics Dept, Medical Faculty, Süleyman Demirel University, Isparta, Turkey
Prof. Dr. Ersan Odacı, MD, Ph.D., Karadeniz Technical University, Medical Faculty, Trabzon, Turkey
Prof. Dr. Elcin Ozgur, Ph.D., Biophysics Department, Faculty of Medicine, Gazi University, Turkey
Prof. Dr. Selim Seker, Electrical Engineering Department, Bogazici University, Istanbul, Turkey
Prof. Dr. Cemil Sert, Ph.D., Department of Biophysics of Medicine Faculty, Harran University, Turkey
Prof. Dr. Nesrin Seyhan, B.Sc., Ph.D., Medical Faculty of Gazi University; Chair, Biophysics Dept; Director GNRK Ctr.; Panel Mbr, NATO STO HFM; Scientific Secretariat Member, ICEMS; Advisory Committee Member, WHO EMF, Turkey
Prof. Dr. Bahriye Sirav (Aral), PhD.,Gazi University Faculty of Medicine, Dept of Biophysics, Turkey
Dr. Oleg Banyra, MD, 2nd Municipal Polyclinic, St. Paraskeva Medical Centre, Ukraine
Prof. Victor Martynyuk, PhD., ECS "Institute of Biology", Head of Biophysics Dept, Taras Shevchenko National University of Kiev, Ukraine
Prof. Igor Yakymenko, Ph.D., D.Sc., Instit. Experimental Pathology, Oncology & Radiobiology, National Academy of Sciences of Ukraine
Michael Bevington, M.A., M.Ed., Chair of Trustees, ElectroSensitivity UK (ES-UK), UK
Mr. Roger Coghill, MA,C Biol, MI Biol, MA Environ Mgt; Member Instit.of Biology; Member, UK SAGE Committee on EMF Precautions, UK
Mr. David Gee, Associate Fellow, Institute of Environment, Health and Societies, Brunel University, UK
Dr. Andrew Goldsworthy BSc PhD, Lecturer in Biology (retired), Imperial College, London, UK
Emeritus Professor Denis L. Henshaw, PhD., Human Radiation Effects, School of Chemistry, University of Bristol, UK
Dr. Mae-Wan Ho, Ph.D., Institute of Science in Society, UK
Dr. Gerard Hyland, Ph.D., Institute of Biophysics, Neuss, Germany, UK
Dr. Isaac Jamieson, Ph.D., Biosustainable Design, UK
Emeritus Professor, Michael J. O'Carroll, PhD., former Pro Vice-Chancellor, University of Sunderland, UK
Mr. Alasdair Phillips, Electrical Engineer, UK
Dr. Syed Ghulam Sarwar Shah, M.Sc., Ph.D., Public Health Consultant, Honorary Research Fellow, BrunelUniversity London, UK
Dr. Sarah Starkey, Ph.D., independent neuroscience and environmental health research, UK
Dr. Obajuluwa Adejoke PhD, Cell Biology and Genetics Unit, Dept of Zoology, University of Ilorin; Lecturer, Biological Sciences Department, Afe Babalola University, Nigeria
Dr. Martin Blank, Ph.D., Columbia University, USA
Prof. Jim Burch, MS, Ph.D., Dept. of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, USA
Prof. David O. Carpenter, MD, Director, Institute for Health and the Environment, University of New York at Albany, USA
Prof. Prof. Simona Carrubba, Ph.D., Biophysics, Daemen College, Women & Children's Hospital of Buffalo Neurology Dept., USA
Dr. Sandra Cruz-Pol, PhD., Professor Electrical Engineering, on Radio Frequencies, Electromagnetics, University of Puerto Rico at Mayaguez; Member of US National Academies of Sciences Committee for Radio Frequencies; Puerto Rico, USA
Dr. Zoreh Davanipour, D.V.M., Ph.D., Friends Research Institute, USA
Dr. Devra Davis, Ph.D., MPH, President, Environmental Health Trust; Fellow, American College of Epidemiology, USA
Dr. James DeMeo, PhD, retired in private research, USA
Paul Raymond Doyon, EMRS, MAT, MA , Doyon Independent Research Associates, USA
Prof. Om P. Gandhi, Ph.D., Department of Electrical and Computer Engineering, University of Utah, USA
Prof. Beatrice Golomb, MD, Ph.D., University of California at San Diego School of Medicine, USA
Dr. Martha R. Herbert, MD, Ph.D., Harvard Medical School, Harvard University, USA
Dr . Gunnar Heuser, M.D., Ph.D., F.A.C.P. Emeritus member, Cedars Sinai Medical Center, Los Angeles, CA; Former Assistant Clinical Professor, UCLA; Former member, Brain Research Institute, UCLA. USA
Dr. Donald Hillman, Ph.D., Professor Emeritus, Michigan State University, USA
Elizabeth Kelley, MA, Fmr. Managing Secretariat, ICEMS, Italy; Director, EMFscientist.org, USA
Dr. Ronald N. Kostoff, Ph.D., Gainesville, VA, USA
Neha Kumar, Founder, Nonionizing Electromagnetic Radiation Shielding Alternatives, Pvt. Ltd; B.Tech – Industrial Biotech., USA
Dr. Henry Lai, Ph.D., University of Washington, USA
B. Blake Levitt, medical/science journalist, former New York Times contributor, EMF researcher and author, USA
Prof. Trevor G. Marshall, PhD, Autoimmunity Research Foundation, USA
Dr. Albert M. Manville, II, Ph.D. and C.W.B., Adj. Professor, Johns Hopkins University Krieger Graduate School of Arts & Sciences; Migratory Bird Management, U.S. Fish & Wildlife Service, USA
Dr. Andrew Marino, J.D., Ph.D., Retired Professor, LSU Health Sciences Center, USA
Dr. Marko Markov, Ph.D., President, Research International, Buffalo, New York, USA
Dr. Jeffrey L. Marrongelle, DC, CCN, President/Managing Partner of BioEnergiMed LLC, USA
Dr. Ronald Melnick, PhD, Senior Toxicologist, (Retired, leader of the NTP's health effects studies of cell phone radio frequency radiation) US National Toxicology Program, National Institute of Environmental Health Sciences, USA
Dr. Samuel Milham, MD, MPH, USA
L. Lloyd Morgan, Environmental Health Trust, USA
Dr. Joel M. Moskowitz, Ph.D., School of Public Health, University of California, Berkeley, USA
Dr. Martin L. Pall, Ph.D., Professor Emeritus, Biochemistry & Basic Medical Sciences, Washington State University, USA
Dr. Jerry L. Phillips, Ph.D. University of Colorado, USA
Dr. William J. Rea, M.D., Environmental Health Center, Dallas, Texas, USA
Camilla Rees, MBA, Electromagnetichealth.org; CEO, Wide Angle Health, LLC, USA
Prof. Narenda P. Singh, MD, University of Washington, USA
Prof. Eugene Sobel, Ph.D., Retired, School of Medicine, University of Southern California, USA
David Stetzer, Stetzer Electric, Inc., Blair, Wisconsin, USA
Dr. Lisa Tully, Ph.D., Energy Medicine Research Institute, Boulder, CO, USA
Supporting Scientists who have published peer reviewed papers in related fields
Olga Ameixa, PhD. Post-Doctoral Researcher, Dept. of Biology & CESAM, University of Aveiro Campus., Universitário de Santiago, Portugal
Michele Casciani, MA, Environmental Science, President/Chief Executive Officer, Salvator Mundi International Hospital, Rome, Italy
Enrico Corsetti, Engineer, Research Director, Salvator Mundi International Hospital, Rome, Italy
Jacques Testart, Biologist, Honorary Research Director at I.N.S.E.R.M. (French National Medical Research Institute), France
Xin Li, PhD candidate MSc, Department of Mechanical Engineering, Stevens Institute of Technology, New Jersey, USA
Dr. Carlos A. Loredo Ritter, MD, Pediatrician, Pediatric Neurologist, President, Restoration Physics, North American Sleep Medicine Society, USADr.
Robin Maytum, PhD, Senior Lecturer in Biological Science, University of Bedfordshire, Luton, UK
Prof. Dr. Raúl A. Montenegro, Ph.D, Evolutionary Biology, National University of Cordoba; President, FUNAM; Recognitions: Scientific Investigation Award from University of Buenos Aires, UNEP 'Global 500' Award (Brussels, Belgium), the Nuclear Free Future Award (Salzburg, Austria), and Alternative Nobel Prize (Right Livelihood Award, Sweden), Argentina.
Dr. Hugo Schooneveld, PhD, Biologist, Neuroscientist, Adviser to the Dutch EHS Foundation, Netherlands
Dr. Carmen Adella Sirbu, MD, Neurology, Lecturer, Titu Matorescu University, Romania
LE RADIAZIONI 5G FANNO MALE, 170 SCIENZIATI PER LA MORATORIA
Next post FERMARE SUBITO IL 5G, NUOVI LIMITI DI SICUREZZA
Previous post INCUBO 5G, IL GOVERNO AUMENTA DI 110 VOLTE L'ELETTROSMOG?
IL PENTAGONO, NON PFIZER O MODERNA, È STATO IL PIONIERE DELLA TECNOLOGIA MRNA CONTRO COVID
UNO STUDIO INQUIETANTE DIMOSTRA CHE LA GENTE STA DIVENTANDO PIÙ STUPIDA: IL QUOZIENTE INTELLETTIVO SCENDE DI 7 PUNTI A OGNI NUOVA GENERAZIONE
VIRUS CHIMERA, GLI ESPERIMENTI PERICOLOSI CONTINUANO
Maria Heibel, 3 Novembre 2022
28 Gennaio 2023 IL "GRANDE RESET ALIMENTARE": CHI C'È DIETRO IL PIANO PER RIORGANIZZARE L'APPROVVIGIONAMENTO ALIMENTARE GLOBALE?
28 Gennaio 2023 I GRANDI DISTRUTTORI DELL'AMBIENTE E DELL'UMANITÀ SE LA CAVANO SENZA PROBLEMI – LA GUERRA CONTINUA AD ESSERE PROPAGANDATA

redpajama_set_name: RedPajamaCommonCrawl


If you're looking to update your make-up bag with a fresh wave of cosmetics and a so-2017 look, holographic make-up could be your new thing.
The trend is all about shiny, space-inspired metallics in pinks, lilacs, blues and silver. Think unicorn meets out-of-this-world chic.
Here's how to pull off the look… some ways are more subtle than others.
Or why not extend the look and just dress head to toe in the holographic look?


text:
import os
import re

# A class representing the list of all the problems
# Used for unit testing the problems and their answers
class Problems:

    @staticmethod
    def get_problems():
        files = [f for f in os.listdir('.') if os.path.isfile(f)]
        problems = []
        for f in files:
            if re.match("[\d\d\d_]", f):
                name_with_number = os.path.splitext(f)[0]
                class_name = os.path.splitext(f)[0][4:]
                _temp = __import__(name_with_number, globals(), locals(), [class_name])
                problem = eval("_temp." + class_name + "()")
                problems.append(problem)
        return problems

Problems().get_problems()

redpajama_set_name: RedPajamaGithub


At work Peggy has carved herself a comfortable niche. Once in hospital, she loses no time in establishing herself as Queen Bee, taking on several responsibilities. Persistently cheerful, blind to the feelings of others and, at heart, terribly lonely, Peggy is at once a richly comic and desperately moving creation, providing a rewarding challenge for a mature actress.


text:
Reproducibility Workshop Draws 1,700 Registrants, 3,500 YouTube Views
CITP faculty member Arvind Narayanan told his co-organizers that he would consider the reproducibility workshop they were planning to be a success if 30 people attended. By the time the July 28 online event went live, more than 1,700 people from 500 institutions and 30 countries had registered for The Reproducibility Crisis in ML-based Science workshop. To the nearly 600 watching via Zoom and YouTube combined, Narayanan, a professor of computer science, declared, "this is a surreal moment for me."
Two weeks later, Wired magazine profiled the work of Narayanan and lead workshop organizer Sayash Kapoor, a CITP Graduate Student, in an August 10 feature story: Sloppy Use of Machine Learning Is Causing a 'Reproducibility Crisis' in Science. Clearly, the pair struck a chord with researchers who, like them, have been wrestling with reproducibility failures in machine learning research and other quantitative sciences.
Their paper, Leakage and the Reproducibility Crisis in ML-based Science, was the impetus for the workshop. In it, Kapoor and Narayanan discuss 20 papers from a variety of fields – including genomics, medicine, software engineering, radiology, satellite imaging, nutrition research, and autism diagnostics – that revealed erroneous or faulty conclusions in at least 329 other papers. Kapoor and Narayanan also propose solutions, including designing a rubric researchers can use for applying machine learning and minimize data leakage.
The workshop, hosted by Princeton's Center for Statistics and Machine Learning, featured presentations from 10 speakers and addressed various factors in what has been dubbed a "reproducibility crisis" — from data leakage to the pressure researchers feel to churn out papers that produce positive results. In addition to Kapoor and Narayanan, the organizers included researchers Priyanka Nanayakkara, a graduate student at Northwestern University; Kenny Peng, an incoming graduate student at Cornell University, and Hien Pham, a Princeton undergraduate.
To access speaker and panel slides and the annotated reading list, please visit The Reproducibility Crisis in ML-based Science workshop website. You may watch the full workshop recording via this video link.


We really hope this brand new Stickman Find Gold 2 iis going to be the newest adventure you all check out and we are sure you are really going to love it so that is why we are here, that is why we are offerinf you the chance to play this new game because we really want you to have a good time and we know you are going to have a good time in this new adventure which is in fact a 3 player adventure and we know you are going to love it. So come and play this brand new Stickman Find Gold 2 and each of you has to control one of the stickmen and you have to do your best to find the gold in all the levels of the game. Good luck!
Stickman Find Gold 2 is one of the 100 games added to 3 Players Games category, that we recommend you to play and then tell us your feedback through a comment in the dedicated section. The game Stickman Find Gold 2 have been played 101 times and this game have been added on 2-Player.com on 03 December 2018, this game have been voted 1 times, and his rate is 100%. This game have been commented 0 times from players that have been played this game.


text:
using System.Collections.Generic;

namespace SupportManager.Api.Users
{
    public class UserDetails
    {
        public int Id { get; set; }
        public string DisplayName { get; set; }
        public string Login { get; set; }
        public List<EmailAddress> EmailAddresses { get; set; }
        public List<PhoneNumber> PhoneNumbers { get; set; }
    }
}


text:
Think getting around College Station is tough now?
College Station residents are highly familiar with seasonal changes to commuter traffic, especially when the students return after the holidays. In the 141 years since Texas A&M was founded as a isolated outpost south of Bryan, the challenges of getting from place to place have shaped the area's distinctive character.
Most people use motor vehicles these days, but that wasn't always the case. College Station's Project HOLD (online library database) chronicles the history of the city's various means of transportation through its collection of historic images. Here's a look at four ways our students — and residents — used to get around:
In the early days, many students arrived and departed from the railroad depot.
Other prospective travelers were more original. In 1897, some intrepid students formed a bicycle club.
For those with a dime to spare, the interurban trolley was a popular mode of transport in the early part of the 20th century.
Finally, it was common for many years to see cadets armed only with an outstretched thumb and a hopeful face, hoping to hitch a ride home between semesters.
As the city approaches the 75th anniversary of its incorporation in October, we invite you to take a closer look at the historic images, documents and memorabilia available in Project HOLD. If you'd like to share your old pictures of College Station's people and places, contact me at heritageprogram@cstx.gov. We'd love to see them!
Jacob Morris
Historic Records Coordinator | Parks & Recreation
This entry was posted on January 16, 2013 by City of College Station. It was filed under Parks and Recreation, Public Communications and was tagged with 75th anniversary, Heritage Programs, Parks and Recreation, Project HOLD.
Anne Boykin
Many times, there were long lines of Aggies hitchiking out of Aggieland. It was first come first serve at the intersection of South College and Sulphur Springs Road which was a traffic circle. The traffic circle is long since gone as is the Circle Drive-In Theater. Now it is the intersection of South College and University Drive. Whenever our family traveled between College Station and Houston, Dallas, Austin, or San Antonio to see family, we never hesitated to pick up Aggies in uniform. My grandfather (AMC '24) and my father (AMC '46) hitchhiked this way to and from A&M when cars were scarce. Years later, my fiance (TAMU '69), hitchhiked home to Dallas on Friday night, borrowed his mother's car, drove back to A&M Saturday morning, took me out on a date Saturday night, drove back to Dallas on Sunday morning and hitchhiked back to A&M on Sunday afternoon. I didn't know he was doing this until some time later. I did wonder why he never asked me out on a Friday night, though. 😉
cooper1959
Hitchhiking was going strong in the early '60s. I made it home to Texas City in as few as one ride and as many as 20. The express was with the guy who designed our new 1958 high school. I think he also designed the 1969 A&M Consolidate High. Another ride was with the fellow who created Pace picante sauce (and it ain't from New York City!).
Hitchhiking etiquette outlawed upstreaming (trying to catch a ride before it got to the hitchhiking line at East Gate). Downstreaming was OK and occasionally someone would pass by the line and then pull over down the road.
-Jerry Cooper


A client we recently worked for had a ClickOnce WPF application developed by some other team who could not figure out how to use the Code Signing certificate from GoDaddy with ClickOnce. Unless the ClickOnce deployment is correctly signed Windows 8 Smart Screen Filter will not let the user install the application in Windows 8. In older versions of Windows, unsigned deployments show a Unverified Publisher message and discourage the users from installing your application. This application was meant to be distributed over the internet and it meant doom for the client who had invested so much in getting the application built, but was being stopped from rollout due to this issue. We were able to resolve the issue for the client with a bumpy ride. This blog post tries to describe the process that worked for us, hopefully it will serve as a guidance to all those who are hitting against a brick wall trying to resolve this issue with very little guidance from GoDaddy documentation.


Altruism is a phenomenon that regularly occurs in social space and affects our everyday lives, but it is something we do not normally put much thought in on a daily basis. Would we feel the urge to help more people if we were placed in different urban life conditions and reminded more often by our city about the importance of being there for our neighbors? If altruism was more widespread, could we feel safer in cities where we live and that we visit? Would people who are now surviving in harsh conditions have more opportunities to develop their settlements and cities? Peter Singer helps us to get a better understanding of human altruistic behavior, its development through time, connection to inhabitable space and sheds some light on the possible antidote to consumerism.
Peter Singer is an Australian moral philosopher. He is currently a Professor of Bioethics at Princeton University and a Laureate Professor at the Center for Applied Philosophy and Public Ethics at the University of Melbourne. He approaches ethical issues from a utilitarian perspective and specializes in applied ethics.
Professor, you study moral blindness. Could you please explain what it is and how it was created?
Moral blindness is something that has evolved because of the situation in which our ancestors, both human and non-human primates lived. And we evolved in small groups… perhaps groups of between one or two hundred people, where we knew every individual. So we developed moral responses to helping other individuals we knew in our group, but we didn't develop any kind of positive attitude to helping people in other groups.
Over the last couple of years we have lived in larger societies, and have only recently got the opportunity to help complete strangers far away due to new technologies. The problem is that we haven't really developed moral emotions that would support us in helping strangers, helping people who are distant from us. The consumer society focuses on personal consumption, status, things of that sort, because people can take advantage of those desires in order to profit.
What effect do bigger cities have on people's behavior?
In smaller cities, even though there might be many thousands, it is still possible to meet someone and have a long term relationship with them, help them today, and they'll help you tomorrow. In bigger cities you encounter a stranger you can help, and there is a very small chance that you'll meet them again, so we don't have those kinds of responses.
Perhaps one way of stimulating people would be to create spaces in which they do get to know each other and meet each other, like small neighborhoods. In Life and death of great American cities Jane Jacobs talks about a lively Italian neighborhood where you go to buy food in a small grocery store. This preserves that sense of small community where you know those people. I think now this is less the case, partly because those small stores have been replaced and partly because half of the people on the streets are tourists. New York would be a classic example of how to preserve that sort of idea. Now that's one way. I don't know if there's another way and that's something I'm interested in doing in my work in which I advocate altruism to strangers.
Do you think we are heading in a positive direction?
I'm reasonably positive about the direction that we're going. I know a lot of people find that surprising because the headlines are always about something bad happening. People think that everything is going downhill but, on a larger scale we are making progress in reducing, for example, the number of deaths of children under five of poverty. For 25 – 30 years it has been pretty steadily going down. So that's good news.
I think we are making some progress, but nobody can be sure of the kinds of directions we're going in. More people have achieved a reasonable level of security, that is, they've got enough income for themselves. They know that if they get sick there's a state health service that will look after them reasonably well, that they won't starve in their old age because of some sort of social security. Those people, I think, will find it easier to be altruistic if they look for a purpose in their life. Helping others, volunteering, being altruistic may be something that they reach towards.
How can technology be used to inspire altruistic behavior?
There are a lot of ideas out there.It could be that every time you use your credit card to buy some luxury item, you get a message on your cell phone that reminds you about this or suggests that you donate a similar amount to some charity.There are a few ideas that are around that people have talked about. Basically, sending reminders like programs that would measure how well you're doing in living a good life from that point of view.
How can we think about the preferences of people who haven't been born yet?
It would be quite wrong of us to ignore or even to discard the interests of future generations. Assuming that there will be some future generations as we can all hope, I think that their interests will count as much as ours. If we think there's some uncertainty about that, if we think that somehow our species might become extinct or also life on earth might become extinct. Then it's reasonable to discount the interests of future generations by the degree of uncertainty about their existence.
People are consistently failing at what they set out to do. In this context, do you think we assume that our own preferences are the ones of the future generations and it is moral from our side to imagine a long way into the future?
I think we should try to keep options open for the future. One of the arguments for preserving endangered species, and preserving historical and cultural monuments is that if we don't, we have closed off that option for future generations. It is far harder to predict what they will value. But keeping options open for them is clearly very important. We have to realize that needs will change, technology will change. So you're always going to make mistakes. Take things around this university for example: tables have these little holes in them so that you could plug your cables in. That was only around for a few years when Wi-Fi made it irrelevant. So, clearly, you can't predict the way technology is going to go. Some mistakes are just going to be inevitable. Some of the basic things about human nature and about the things that what are fundamental human needs, I wouldn't see this changing in quite some time.
What would be your advice to future urban planners?
Create cities that meet human needs and not only for the people that are living in them at the time, but also that meet the needs of others worldwide. Cities with a sustainability aspect in them, those that try to create better societies in which people are more aware of the needs of others both near to them and those that are far away.


We have a number of shooting sports, dog, horse, small animals, livestock sale and program flyers in the Extension Office. They are posted on the display board at the Extension Office for you to look at or online. To see what state wide contests, jackpots, shows or sales we have been notified about, go to the Shooting Sports, Dog, Horse and Livestock Shows, Jackpots and Contests page.


For what it's worth, the Washington Post reports that 22-year-old alleged Tucson shooter Jared Lee Loughner is a registered independent.
Six people were left dead and 14 injured, including Democratic Rep. Gabrielle Giffords of Arizona, after a gunman believed to have been Loughner open fired at town hall-style meeting on Saturday at a grocery store in Tucson, Ariz.
Though the evidence seems to indicate Loughner lacks a fixed ideology (outside of anti-government sentiment) and may be mentally unstable, many have drawn conclusions about his political leanings. Some have cast him as a conservative and blamed Sarah Palin and Tea Party influences for his actions, while others have cast him as a "lunatic liberal."
Loughner himself isn't talking. But the record shows that he registered as an independent in 2006, according to the Pima County Registrar of Voters, and did not vote in 2010.
Bryce Tierney, a friend of Loughner's, told Mother Jones magazine that Loughner doesn't have any specific political or ideological bent. "It wasn't like he was in a certain party or went to rallies," he said. "It's not like he'd go on political rants."
Jared Loughner's Parents "Hurting Real Bad"


text:
Rikomatic
Musings on Dance, Food, Geek Stuff
Check out my Professional Site RangerRik.com
Quakers, Participatory Culture, and Our Mission in the World
A few weeks ago, I went to a really interesting talk by Wess Daniels on Quakers and mission at the lovely Friends Church of Berkeley. Wess is a doctoral student and a released minister from Camas Friends Church in Washington. I really had not idea what to expect, other than the fact that a cross-section of Friends from a number of different Quaker Meetings and Churches would likely be there.
Wess made a number of interesting points that I'm sure other Quakers who were there will be recounting on their blogs. I wanted to focus on the part that was most relevant to me, his comparison of "participatory culture" and Quakerism.
Wess's thesis is that participatory culture can help us to better understand the role of Quakers in the role, our "mission" as seekers of the Light. As a Quaker who has spent a good part of his career focusing on participatory culture, and seeking personal direction, it was like Wess was speaking directly to my condition.
I won't try to summarize Wess's points in detail, which I won't do justice to. Wess explained some of the basic attributes of participatory culture, as described by folks like Henry Jenkins and Pierre Levy, including "remix," "collective intelligence," and "alternative social community." He then went through these attributes to explain how much these aligns with Quaker spirituality and community.
I think that Wess has many valid points and compelling arguments about how Quakers have been a countercultural force for much of our history, and how that informs how we see our own role in the world today. I found a lot of sense in his argument that Quakers have always challenged heirarchical religious authorities of the day, in a similar sense that creators of online media challenge the more centralized channels of mass media. And our communities are formed through the practice of Quakerism, which can be seen as analagous to how fanfic, machinima, or 8-bit music communities are formed through the process of media production.
That said, I think it is much less clear what lesson participatory culture teaches to Quakers about how to impact the world. Much of the new kinds of civic engagement that emerges from digital culture has to do with remixing popular tropes and products and remixing them in ways that entertain, inform and spur to action. For example, check out what happens when environmentalists produce their own videos about the Chevy Tahoe SUV using the Chevrolet company's own video creation tools! Or witness Harry Potter fans taking their love of this popular escapist fantasy and using it to spur action on real world crises like in Haiti and Darfur.
By contrast, my experience of Quakers has been of a people who are largely, and proudly, divorced from popular culture. I know many Quakers, myself included, who don't own televisions, Quakers who don't listen to current popular music, don't go to the movies except to see documentaries, don't spend much time online except to get emails from FCNL. A good example you could see among the many Quakers at Wess's talk who didn't know what fanfic, zines, or mashups were.
While these sorts of disconnections from common culture might make us smarter, perhaps even wiser, I don't know if they do much to connect us to others in our larger communities we live in. Are we literally speaking a different language that will not speak to the condition of those around us? As many of the new forms of activism and political discourse move online to FaceBook, Twitter, and the blogosphere, are we still just picketing for peace in the town square?
From my perspective as a blogger and a virtual world educator, I of course am convinced that Quakers can useful engage the world with their message through participatory culture. If anything, the current environment of participatory online culture is a much better environment for Quakers to spread their message to the world than the mass media channels of broadcast television, cinema or long-form print publications. So the question for myself becomes, how can I as a Friend help other Quakers usefully contribute to the larger online culture in ways that express our values and invite others into our radical community?
For more Quaker commentary and discussion around Wess Daniel's talk on Quakers and mission, see Wess's website, Robin Mohr's blog, and Lisa H's two posts about Quakers and remix (one and two).
4 thoughts on "Quakers, Participatory Culture, and Our Mission in the World"
Robin Mohr says:
I think my favorite tweet of the day was yours – about how Wess had to explain remix, zines and realized eschatology in the same session. I felt so hip and with it that I knew all the words, even if I'm not really in touch with any of them.
I think that there are Quakers who engage in more popular culture than they admit at Meeting, and there are more people who would be Quakers if it didn't mean they had to hide their affinity for various elements of pop culture.
For me, one of the important things is the aha moment when I realize that I don't have to take pop culture as is – that I can participate, can flip the meaning, can remix the pieces that speak to me with my own critique and enthusiasm (shedding Light on the situation, so to speak).
Wess says:
Rik – it was a real pleasure to meet you during QHD and I really appreciated that you are far more an insider to this stuff than even I am. Thanks for all your stimulating questions and ideas and thanks for this great review.
In terms of your last question. I guess that parts kind of for each of us in our particular settings to figure out! 😉
Steven Davison says:
I think leadership in using participatory culture to impact the world is likely to come from young Friends, so I've been thinking lately about how that might work. One idea is "Q-Tube": young Friends creating short videos describing why they are Quakers or exploring how the testimonies or other aspects of Quaker faith and practice guide them in their lives.
I recently served as an Quaker adult presence at a high school gathering of young Friends and was really impressed with how articulate, thoughtful, heartfelt and engaged these folks were, not to mention loving and fun-loving. I came away uplifted and inspired and much encouraged about the future of Quakerism.
I couldn't quite tell how close to popular culture these young people are living. I didn't stay long enough, didn't get to know them well enough. But I imagine they're way more involved than many of us older Friends, and that we might soon see some creative work bubbling up.
This brings to mind the early Friends as Publishers of Truth, and Wess' mention of the sheer quantity of tracts by Quakers. I can't remember where or when I heard that at one time 1/4 of the English were Quakers; whether or not that's accurate, we must have been very visible.
The other times I can think of when Quakers have been very visible are:
— during the abolition and women's suffrage movements (lots of public speaking, demonstrations, going to jail);
— during and after World War II (feeding the Germans, assisting Japanese Americans who were in internment camps, civilian service by conscientious objectors, AFSC winning the Nobel Peace Prize);
— during the Vietnam War (draft counseling, peace vigils, enough organizing and protests for the FBI to amass huge files on us).
Much of this work has involved responding to need, speaking out bravely, defying government on moral grounds, joining in coalition with people of other faiths. I think we still do these things, but more on an individual basis than en masse. Are we waiting for our meetings to approve some kind of common witness? Did we do the work I've listed above as meetings, or as individuals with leadings?
When else have we been visible? How are we visible now?
I think you're right that online participatory culture is a good way to voice our concerns. But where do we need to show up to participate with others, to be mutually heard, to address real needs, to stand up in ways that make a difference?
Freestyle to "Booty Swing" by Parov Stelar
https://www.youtube.com/watch?v=K3pMWtX0DdE
"I need to get back to my crew"
The Best G-D Buttermilk Biscuits (recipe)
Porg Pot Pie (recipe)
How to Blind Bake a Pie Crust
What I Learned from 12 Months of Intermittent Fasting
Dancing / Music
Frankie Manning
Media Reform
Real World Places in SL
b-boy (74) breakdance (50) breaking (26) brooklyn (36) charleston (12) competition (11) coney island (10) dance (17) dancing (30) documentary (15) education (21) festival (12) frankie95 (16) frankie manning (51) frim fram (10) global kids (70) hip-hop (31) human rights (11) inaug09 (11) jazz (12) lindy hop (139) lindyhop (17) lowcarb (18) lxd (11) macarthur foundation (12) machinima (22) memorial (14) mermaidparade (22) mtv (13) performance (16) pmt (10) popping (11) quaker (27) recipe (35) rockclimbing (16) second life (81) shim sham (15) skating (14) soul music (14) swing (51) swing dance (45) united nations (10) virtual world (19) virtual worlds (29) yehoodi (38)
© 2021 Rikomatic | Powered by Superbs Personal Blog theme


text:
// Generated by the protocol buffer compiler.  DO NOT EDIT!
// source: google/analytics/admin/v1beta/analytics_admin.proto

package com.google.analytics.admin.v1beta;

public interface GetDataStreamRequestOrBuilder
    extends
    // @@protoc_insertion_point(interface_extends:google.analytics.admin.v1beta.GetDataStreamRequest)
    com.google.protobuf.MessageOrBuilder {

  /**
   *
   *
   *

   * Required. The name of the DataStream to get.
   * Example format: properties/1234/dataStreams/5678
   *

   *
   *
   * string name = 1 [(.google.api.field_behavior) = REQUIRED, (.google.api.resource_reference) = { ... }
   *
   *
   * @return The name.
   */
  java.lang.String getName();
  /**
   *
   *
   *

   * Required. The name of the DataStream to get.
   * Example format: properties/1234/dataStreams/5678
   *

   *
   *
   * string name = 1 [(.google.api.field_behavior) = REQUIRED, (.google.api.resource_reference) = { ... }
   *
   *
   * @return The bytes for name.
   */
  com.google.protobuf.ByteString getNameBytes();
}


Turning back the clock to the 2010 departure of Dean Pees, the New England Patriots are once again preparing to go into a season without a defensive coordinator, according to two league sources who spoke to Yahoo Sports.
The Patriots have not named a defensive coordinator since the departure of Matt Patricia, who left to become the head coach of the Detroit Lions last month. The Patriots will turn over primary defensive play-calling duties to linebackers coach Brian Flores, a source said. The move mirrors New England's grooming process of Patricia, who was given defensive play-calling duties for the Patriots following the 2010 departure of Pees, New England's former defensive coordinator. Patricia's title was not officially promoted to defensive coordinator until 2012.
Despite the move not being a titled promotion, the added responsibility continues a significant rise by the 37-year-old Flores, who has coached New England's linebackers since 2016. Flores started his career as a Patriots scouting assistant in 2004 after playing linebacker at Boston College. He worked in New England's personnel department until transitioning to the coaching staff in 2008. Despite operating behind the Patriots curtain for the past 14 seasons, Flores' star has risen as players and staffers have left the Patriots and shared his name with new staffs. So much so, he received his first head coaching interview in January with the Arizona Cardinals.
"Brian was a guy I didn't know a lot about," Cardinals general manager Steve Keim told Patriots.com at the scouting combine last week. "[He] had the recommendations from a lot of different people. Was really impressed with him in the interview process, maybe a little bit more just about his presence.